CUSIP 22053A107COMQNCXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
67 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 2.67M | $8.95M | −401.3K | Reduced |
| 2 | Adage Capital Partners Gp, L.L.C. | 2.25M | $7.54M | +2.25M | New |
| 3 | Vanguard Group Inc | 2.08M | $6.98M | +320.6K | Added |
| 4 | Woodline Partners LP | 1.94M | $6.50M |
| +1.94M |
| New |
| 5 | Millennium Management LLC | 1.19M | $3.99M | −196.4K | Reduced |
| 6 | Ieq Capital, LLC | 979.3K | $3.28M | −2.0K | Reduced |
| 7 | Almitas Capital LLC | 930.1K | $3.12M | +435.4K | Added |
| 8 | Superstring Capital Management LP | 858.7K | $2.88M | +858.7K | New |
| 9 | Stempoint Capital LP | 739.3K | $2.48M | +739.3K | New |
| 10 | Renaissance Technologies LLC | 538.1K | $1.80M | +69.5K | Added |
See every fund holding Quince Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders